Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05341739 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 5, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Jul 2024 to Nov 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2024 to Nov 2025
    • Site details revised
    v3
  2. Minor Site contact updatedv2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a research study to determine if performing stereotactic radiosurgery (SRS) prior to surgical resection of the brain metastasis (tumor) will improve local control, in other words, increase the possibility of total removal of the primary tumor without local recurrence on longterm follow up. This research study will also determine if pre-operative SRS will lower the risk of radionecrosis that is the breakdown of body tissue at the original tumor site, and the development of leptomeningeal disease.
Trial Details
NCT Number NCT05341739
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborators: Elekta Limited
Conditions
(from sponsor)
Brain Metastases, Adult
Related terms Brain Neoplasms
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov